The role of lipid and carbohydrate digestive enzyme inhibitors in the management of obesity: a review of current and emerging therapeutic agents
about
Low serum amylase and obesity, diabetes and metabolic syndrome: A novel interpretationLactobacillus gasseri SBT2055 suppresses fatty acid release through enlargement of fat emulsion size in vitro and promotes fecal fat excretion in healthy Japanese subjects.Coconut-derived D-xylose affects postprandial glucose and insulin responses in healthy individuals.Structure-Based Optimization and Biological Evaluation of Pancreatic Lipase Inhibitors as Novel Potential Antiobesity Agents.The inhibitory activity of herbal medicines on the keys enzymes and steps related to carbohydrate and lipid digestion.Effects of surfactants on lipase structure, activity, and inhibition.Modulation of metabolic syndrome-related inflammation by cocoa.Recent approaches of lipid-based delivery system for lymphatic targeting via oral route.Starch Digestion-Related Amylase Genetic Variant Affects 2-Year Changes in Adiposity in Response to Weight-Loss Diets: The POUNDS Lost Trial.Postprandial effects of a polyphenolic grape extract (PGE) supplement on appetite and food intake: a randomised dose-comparison trial.Ayurvedic anti-diabetic formulation Lodhrasavam inhibits alpha-amylase, alpha-glucosidase and suppresses adipogenic activity in vitro.Potential of rooibos, its major C-glucosyl flavonoids, and Z-2-(β-D-glucopyranosyloxy)-3-phenylpropenoic acid in prevention of metabolic syndrome.Antihyperglucolipidaemic and anticarbonyl stress properties in green, yellow and red sweet bell peppers (Capsicum annuum L.).Microencapsulation of tannic acid for oral administration to inhibit carbohydrate digestion in the gastrointestinal tract.The Postprandial Anti-Hyperglycemic Effect of Pyridoxine and Its Derivatives Using In Vitro and In Vivo Animal Models.Medicinal Plants Traditionally Used for Treatment of Obesity and Diabetes Mellitus - Screening for Pancreatic Lipase and α-Amylase Inhibition.
P2860
Q28066021-86CA3AC4-615D-4499-BFDB-E7F8F88A7AACQ35339196-30CA1A94-4804-4560-AD62-A802DD9302CFQ35675502-4FC34727-6BFB-40BE-8B7E-8D44BB71EC0AQ35807262-EC7D3060-9CEC-440A-8679-2D508460C2EFQ36183233-80ED24D5-65F7-4158-9425-3094D8414688Q37828446-63F3AA33-ACB7-449D-B34C-3AF3D1D9C914Q38103512-B521282B-1E43-4550-A1EA-1498D1E1A06AQ38242314-2209F2E8-D818-49BA-B486-F489ED9A2AF2Q39062361-2B1784EC-9415-4493-949B-BDF18B866C1BQ40539441-118D8955-9B88-4457-ADAB-D615D27F263FQ41689075-B627A6B3-D4EC-417F-BE9E-F0A3D838A7BFQ48199112-07540C95-3F0C-43F1-9406-E2B3506A5DBAQ50436900-1D6C2885-F017-4B90-9E2B-00ADAD094008Q50480955-D109E91E-CBD3-4830-8749-12D614EDB5CEQ51745706-F3F81CB3-2A4B-4C54-814C-7D96723DBF11Q52859916-DBEF5CEC-4F06-42D7-A482-6D419838D272
P2860
The role of lipid and carbohydrate digestive enzyme inhibitors in the management of obesity: a review of current and emerging therapeutic agents
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
The role of lipid and carbohyd ...... nd emerging therapeutic agents
@ast
The role of lipid and carbohyd ...... nd emerging therapeutic agents
@en
The role of lipid and carbohyd ...... nd emerging therapeutic agents
@nl
type
label
The role of lipid and carbohyd ...... nd emerging therapeutic agents
@ast
The role of lipid and carbohyd ...... nd emerging therapeutic agents
@en
The role of lipid and carbohyd ...... nd emerging therapeutic agents
@nl
prefLabel
The role of lipid and carbohyd ...... nd emerging therapeutic agents
@ast
The role of lipid and carbohyd ...... nd emerging therapeutic agents
@en
The role of lipid and carbohyd ...... nd emerging therapeutic agents
@nl
P2093
P2860
P356
P1476
The role of lipid and carbohyd ...... nd emerging therapeutic agents
@en
P2093
Emma J Boyland
Jason Cg Halford
Sonia A Tucci
P2860
P304
P356
10.2147/DMSOTT.S7005
P577
2010-05-10T00:00:00Z